Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Gout and Crystalline Arthritis

Letter to the Editor

Alan Zalkowitz, MD  |  November 1, 2010

Feedback from our Readers

Aggressive Urate Lowering Needed for Gout

Kathy Holliman  |  July 1, 2010

Patients with gout at increased risk for cardiovascular disease and adverse event

Colcrys Approval Triggers Questions

Kurt Ullman  |  May 1, 2010

Some rheumatologists question the depth of research and the approval’s implications for patient access

The Law of Unintended Consequences Rears Its Head

Stanley B. Cohen, MD  |  April 1, 2010

A program to improve drug safety has increased drug prices for patients with gout and FMF

ALERT: 2010 ICD-9-CM/CPT Code Changes

From the College  |  February 1, 2010

As of January 1, physicians can no longer bill the inpatient/outpatient consultation evaluation and management (E/M) codes for Medicare patients. E/M codes for new or established patients should be used as appropriate.

ALERT: 2010 ICD-9-CM/CPT Code Changes

From the College  |  January 1, 2010

As of January 1, physicians can no longer bill the inpatient/outpatient consultation evaluation and management (E/M) codes for Medicare patients. E/M codes for new or established patients should be used as appropriate.

Reading Rheum

Staff  |  December 1, 2009

Handpicked Reviews of Contemporary Literature

Doctor or Accountant?

Stanley B. Cohen, MD  |  December 1, 2009

Complex coding and reimbursement rules can detract from patient care

Gout

Staff  |  March 1, 2009

Patient Fact Sheet

Pseudogout

From the College  |  July 1, 2008

Pseudogout is a type of arthritis that, as the name implies, can cause symptoms similar to gout, but which are a reaction to a different type of crystal deposit. This type of arthritis may be one of the most misunderstood forms, and is often mistaken for gout and other conditions, including RA. Proper diagnosis is important because untreated pseudogout may lead to a severe form of joint degeneration and ongoing inflammation, resulting in chronic disability.

  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences